Krystal Biotech (KRYS) Assets Growth (3y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.97% |
| Dec 31, 2025 | 33.67% |
| Sep 30, 2025 | 29.10% |
| Jun 30, 2025 | 23.71% |
| Mar 31, 2025 | 20.32% |
| Dec 31, 2024 | 19.02% |
| Sep 30, 2024 | 29.62% |
| Jun 30, 2024 | 27.42% |
| Mar 31, 2024 | 24.42% |
| Dec 31, 2023 | 38.08% |
| Sep 30, 2023 | 36.40% |
| Mar 31, 2023 | 37.38% |
| Dec 31, 2022 | 38.76% |
| Sep 30, 2022 | 39.08% |
| Jun 30, 2022 | 43.11% |
| Mar 31, 2022 | 74.70% |
| Dec 31, 2021 | 75.37% |
| Sep 30, 2021 | 102.34% |
| Jun 30, 2021 | 112.80% |
| Mar 31, 2021 | 109.98% |
| Dec 31, 2020 | 83.74% |
| Sep 30, 2020 | 80.83% |
| Dec 31, 2019 | 357.56% |